AzTrials
AzTrials

Head InjuryNCT07872865

Outcomes of Early Versus Late Tracheostomy in Critically Ill Patients Due to Head Injury: A Randomized Controlled Trial

A study testing Tracheostomy in people with Head Injury and Traumatic Brain Injury, run by University Of Anbar at 1 site in Iraq.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tracheostomy is a surgical procedure that involves creating an opening in the trachea and bringing it to the skin surface to form a stoma. It may be performed as an emergency or elective operation. Read more about this study

Who is it for?
Ages 10 years and older
Conditions the study is for
Head Injury, Traumatic Brain Injury
What is being tested?
Tracheostomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteIraq
Study dates
7 Jan 2026to 25 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients aged ≥10 years.
  • Isolated traumatic head injury (blunt or penetrating), or traumatic head injury associated with other trauma.
  • Expected to require invasive mechanical ventilation for at least 72 hours, as judged by the treating intensivist or neurosurgeon.
  • Endotracheal intubation performed during the current hospital admission.
  • Enrollment within 48 hours of ICU admission.

Who cannot join

  • Prior tracheostomy during the same hospital admission.
  • Irreversible brain injury with anticipated withdrawal of life-sustaining treatment within 72 hours.
  • Uncorrectable coagulopathy precluding tracheostomy, including platelet count <50 × 10^9/L despite transfusion or INR >1.8 despite correction.
  • Uncontrolled intracranial hypertension prohibiting safe positioning for tracheostomy despite optimal management.
  • High cervical spine instability contraindicating positioning for tracheostomy, based on neurosurgical assessment.
  • Known pregnancy.
  • Enrollment in a conflicting interventional trial.
  • Prisoners or other vulnerable groups as defined by local regulations.

Trial locations and contacts

1 site in 1 country.

Iraq1 site
  • University of Anbar, College of Medicine

    Ramadi, Al-Anbar Governorate, 31001

Other trials in Iraq

About this study

Tracheostomy is a surgical procedure that involves creating an opening in the trachea and bringing it to the skin surface to form a stoma. It may be performed as an emergency or elective operation. The main indications include relief of upper airway obstruction, protection of the lower respiratory tract, and facilitation of assisted ventilation in critically ill patients. Further studies are needed to identify the patient populations that may benefit from early tracheostomy. Therefore, this study was conducted to evaluate early tracheostomy (≤7 days) compared with late tracheostomy (>7 days) in relation to the occurrence of ventilator-associated pneumonia, duration of mechanical ventilation, length of hospital stay, and 30-day mortality in critically ill patients with traumatic head injury.

Read the detailed description

This study was a prospective, randomized, parallel-group, open-label controlled trial conducted among critically ill adult patients with traumatic brain injury requiring invasive mechanical ventilation.

Eligible participants were randomly assigned in a 1:1 ratio to either an early tracheostomy group or a late tracheostomy group. In the early tracheostomy group, tracheostomy was performed within 7 days of endotracheal intubation. In the late tracheostomy group, tracheostomy was performed more than 7 days after endotracheal intubation.

Due to the nature of the intervention, blinding of participants, treating physicians, and other care providers was not feasible. Both groups otherwise received standard intensive care and traumatic brain injury management according to the clinical protocols of the treating institution.

The primary outcome was the occurrence of ventilator-associated pneumonia during ICU admission. Secondary outcomes were 30-day all-cause mortality, duration of mechanical ventilation, ICU length of stay, and hospital length of stay.

Clinical and demographic information was collected using standardized data collection forms. Recorded variables included participant characteristics, severity of traumatic brain injury, Glasgow Coma Scale score, relevant radiological and clinical findings, timing of tracheostomy, occurrence of ventilator-associated pneumonia, duration of mechanical ventilation, ICU length of stay, hospital length of stay, and mortality status.

A total of 100 participants were included in the final study population. Outcomes were compared between the early and late tracheostomy groups using appropriate statistical methods for continuous and categorical variables. Statistical significance was defined as a P value of less than 0.05.

The study was conducted following approval from the responsible ethical review authority, and informed consent was obtained from the participant or legally authorized representative as applicable.

Being tested
Tracheostomy
Keywords
Early tracheostomy, Late tracheostomy, Tracheostomy, Critically ill patients, Head injury, traumatic brain injury, Tracheostomy Timing, Ventilator-associated pneumonia
Medical subject headings
Craniocerebral Trauma, Brain Injuries, Traumatic, Pneumonia, Ventilator-Associated

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TracheostomyProcedure or surgery

    Tracheostomy performed in critically ill patients with traumatic brain injury according to randomized assignment to either early tracheostomy within 7 days of endotracheal intubation or late tracheostomy after 7 days.

Study groups in NCT07872865
Study groupRoleWhat they receive
Early tracheostomyExperimentalParticipants with traumatic brain injury assigned to undergo tracheostomy within 7 days of endotracheal intubation.
Receives: Procedure: Tracheostomy
Late tracheostomyActive comparatorParticipants with traumatic brain injury assigned to undergo tracheostomy more than 7 days after endotracheal intubation.
Receives: Procedure: Tracheostomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ventilator-Associated Pneumonia

    Ventilator-associated pneumonia was assessed from 48 hours after endotracheal intubation until ICU discharge, death, or 30 days after intubation, whichever occurred first.

    Measured: Up to 30 days after ICU admission.

Secondary outcomes (4)
  1. 30-Day All-Cause Mortality

    Proportion of participants who died from any cause within 30 days after tracheostomy.

    Measured: 30 days after tracheostomy.

  2. ICU Length of Stay

    Number of days from ICU admission until ICU discharge or death.

    Measured: Up to 30 days after ICU admission.

  3. Duration of Mechanical Ventilation

    number of days from initiation of invasive mechanical ventilation until successful liberation from mechanical ventilation or death.

    Measured: Up to 30 days after endotracheal intubation.

  4. Hospital Length of Stay

    Number of days from hospital admission until hospital discharge or death.

    Measured: Up to 30 days after hospital admission.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2026
  2. Study start7 Jan 2026
  3. Primary completion25 Sep 2026
  4. Study completion25 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned to either early tracheostomy or late tracheostomy groups and were followed in parallel to compare clinical outcomes.
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07872865
Sponsor's protocol ID
SRC-2
Status last verified
Oct 2026
First submitted
1 Oct 2026
Last updated
14 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Terragni P, Faggiano C, Martin EL, Ranieri VM. Tracheostomy in mechanical ventilation. Semin Respir Crit Care Med. 2014 Aug;35(4):482-91. doi: 10.1055/s-0034-1383862. Epub 2014 Aug 11.

    PubMed 25111644
  • Boni A, Tonietto TA, Rihl MF, Viana MV. Early versus late tracheostomy in critically ill patients: an umbrella review of systematic reviews of randomised clinical trials with meta-analyses and trial sequential analysis. BMJ Open Respir Res. 2025 Apr 5;12(1):e002434. doi: 10.1136/bmjresp-2024-002434.

    PubMed 40187743
  • Dempsey GA, Morton B, Hammell C, Williams LT, Tudur Smith C, Jones T. Long-Term Outcome Following Tracheostomy in Critical Care: A Systematic Review. Crit Care Med. 2016 Mar;44(3):617-28. doi: 10.1097/CCM.0000000000001382.

    PubMed 26584197
  • Young D, Harrison DA, Cuthbertson BH, Rowan K; TracMan Collaborators. Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial. JAMA. 2013 May 22;309(20):2121-9. doi: 10.1001/jama.2013.5154.

    PubMed 23695482

Questions about this trial

What is this clinical trial studying?

A study testing Tracheostomy in people with Head Injury and Traumatic Brain Injury, run by University Of Anbar at 1 site in Iraq.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ventilator-Associated Pneumonia (time frame: Up to 30 days after ICU admission.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07872865, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in